Spyryx Biosciences Overview
- Year Founded
-
2013

- Status
-
Out of Business
- Employees
-
10

- Latest Deal Type
-
Out of Business
Spyryx Biosciences General Information
Description
Operator of a privately held, clinical-stage biopharmaceutical company intended to create innovative therapeutics to address severe lung diseases. The company's therapeutics utilizes inhaled peptides to treat severe pulmonary diseases where mucus accumulation and obstructions are key to disease progression, enabling healthcare institutes to get peptide for the treatment of orphan lung and respiratory diseases like Cystic Fibrosis and Chronic Obstructive Pulmonary Disorder.
Contact Information
Website
www.spyryxbio.comCorporate Office
- 801-10 Capitola Drive
- Durham, NC 27713
- United States
Corporate Office
- 801-10 Capitola Drive
- Durham, NC 27713
- United States
Spyryx Biosciences Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
4. Out of Business | 01-Sep-2019 | Completed | Out of Business | |||
3. Later Stage VC | 04-Oct-2018 | Completed | Clinical Trials - Phase 2 | |||
2. Grant | 20-Jun-2017 | $5M | $18.2M | Completed | Clinical Trials - Phase 2 | |
1. Early Stage VC (Series A) | 24-Apr-2015 | $18.2M | $18.2M | Completed | Product Development |
Spyryx Biosciences Cap Table
Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
---|---|---|---|---|---|---|---|---|
Series A |
Spyryx Biosciences Comparisons
Industry
Financing
Details
Spyryx Biosciences Competitors (75)
One of Spyryx Biosciences’s 75 competitors is Verona Pharma, a Private Debt Financed company based in London, United Kingdom.
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Verona Pharma | Private Debt Financed | London, United Kingdom | ||||
Theravance Biopharma | Corporation | San Francisco, CA | ||||
Edesa Biotech | Formerly VC-backed | Markham, Canada | ||||
The Zambon Group | Private Debt Financed | Bresso, Italy | ||||
Rallybio | Formerly VC-backed | New Haven, CT |
Spyryx Biosciences Patents
Spyryx Biosciences Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
EP-3554527-A1 | Saline formulations of splunc1 peptides | Inactive | 13-Dec-2016 | ||
CA-3046361-A1 | Saline formulations of splunc1 peptides | Inactive | 13-Dec-2016 | ||
US-20200031866-A1 | Peptide inhibitors of sodium channels | Inactive | 29-Sep-2016 | ||
AU-2015330895-A1 | Improved peptide inhibitors of sodium channels | Inactive | 08-Oct-2014 | ||
US-9796768-B2 | Peptide inhibitors of sodium channels | Inactive | 08-Oct-2014 | C07K7/06 |
Spyryx Biosciences Signals
Spyryx Biosciences FAQs
-
When was Spyryx Biosciences founded?
Spyryx Biosciences was founded in 2013.
-
Where is Spyryx Biosciences headquartered?
Spyryx Biosciences is headquartered in Durham, NC.
-
What is the size of Spyryx Biosciences?
Spyryx Biosciences has 10 total employees.
-
What industry is Spyryx Biosciences in?
Spyryx Biosciences’s primary industry is Pharmaceuticals.
-
Is Spyryx Biosciences a private or public company?
Spyryx Biosciences is a Private company.
-
What is Spyryx Biosciences’s current revenue?
The current revenue for Spyryx Biosciences is
. -
How much funding has Spyryx Biosciences raised over time?
Spyryx Biosciences has raised $29.1M.
-
Who are Spyryx Biosciences’s competitors?
Verona Pharma, Theravance Biopharma, Edesa Biotech, The Zambon Group, and Rallybio are some of the 75 competitors of Spyryx Biosciences.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »